Company News in the Life Science Industry

»

Reset 

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  Avid Bioservices Inc. | Avid Bioservices, Inc.

Teligent Announces Conversion Rate Adjustment for its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes Due 2023 and its 4.75% Convertible Senior Notes Due 2023

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  Teligent, Inc.

Jushi Holdings Inc. Announces Voting Results of Annual and Special Meeting

Read more ››
By: GlobenewsWire - 03 Jun 2020

Uniting for a people's vaccine against Covid-19

NEW YORK, 03 June 2020 / PRN Africa / -- The United Nations and the International Red Cross and Red Crescent Movement call for unity to scale up efforts to develop, test, and scale-up production of safe, effective, quality, affordable diagnostics, therapeutics, medicines and vaccines. Specifically,... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering

HANGZHOU, China, June 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company" or "China Jo-Jo"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

Arix to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference

LONDON, June 3, 2020 /PRNewswire/ -- Arix Bioscience plc ("Arix") (LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that Jonathan Tobin, PhD, Managing Director, is scheduled to participate in an analyst led fireside... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

Global 3D Printing Medical Device Markets to 2024 - Technology Readiness, Competitive Intensity, Regulatory Compliance, Disruption Potential, Trends, Forecasts and Strategic Implications

DUBLIN, June 3, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

MSC Therapy for Acute Respiratory Distress Syndrome; It's Time to Accelerate Clinical Trials for COVID-19 Patients in Need

WASHINGTON, June 3, 2020 /PRNewswire/ -- A new systematic... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020
Related companies:  Regenerative Medicine Foundation

Global Sleep Apnea Devices Market (2019 to 2026) - by Products, Application, End-users and Geography

DUBLIN, June 3, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

Exceptional Emergency Centers Now Accepting Medicare

DALLAS, June 3, 2020 /PRNewswire/ -- In April, the Centers for Medicare & Medicaid Services announced that independent, Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

The infusion pumps market is expected to grow at a CAGR of over 8% during the period 2019-2025

NEW YORK, June 3, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 03 Jun 2020

Remote Patient Monitoring Device Market Report 2020 - Assessment by Product, Type, End-user and Region (2018-2027)

DUBLIN, June 3, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

Mile High Labs is Proud Supplier to New CarryOn™ CBD-infused Beverages

Leading CBD producer supports launch of CarryOn™, a new brand driven by product innovation to normalize pursuit of mental wellbeing

Read more ››
By: PR Newswire Association LLC. - 03 Jun 2020

Zeulide Depot(TM) is now Covered by the Ontario Drug Benefit (ODB) Program for Patients Living with Prostate Cancer

TORONTO, June 3, 2020 /CNW/ - Verity Pharmaceuticals Inc. is pleased to announce that as of May 29, 2020, Zeulide Depot(TM) (Leuprolide acetate for depot suspension), a hormone therapy for the palliative treatment of prostate cancer, has been added as a General Benefit through the Ontario Drug... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial Officer

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  22nd Century Group, Inc.

Aclaris Therapeutics Announces Publication of an Abstract of the Phase 1 Clinical Trial Results for ATI-450, an Investigational Compound, at the EULAR 2020 E-Congress

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  Aclaris Therapeutics, Inc.

Pluristem Joins Forces with CRISPR-IL National Consortium to Advance Development of Cutting-Edge Genome Editing Solutions for Life Science Products

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  Pluristem Therapeutics Inc.

HEXO launches new Tsunami 30 g flower format exclusively to medical clients

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  HEXO Corp.

Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  Applied Therapeutics, Inc.

Replimune Provides RP1 Data Update from its Phase 2 Cohorts in Melanoma and Non-Melanoma Skin Cancer that Strongly Support Replimune’s Ongoing Registration-Directed Clinical Trials with RP1

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  Replimune Inc.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies